• Utah Medical Products’ third-quarter 2026 diluted earnings rose 7% year over year to $0.876 per share.
• Quarterly revenue fell 12% to $8.62 million, largely due to lost business from two previously major customers.
• For January–September 2026, diluted earnings dropped 5% to $2.537 per share, while revenue declined 12% to $25.87 million year over year.
• Femcare acquired UK-based Orion Medical Supplies at August’s end for $5.01 million, including acquisition costs; Orion contributed $619,000 in third-quarter revenue.
• Management projects a full-year 2026 revenue decline close to 7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610220900ACCESSWRNAPR_____1239791) on October 22, 2026, and is solely responsible for the information contained therein.